OBJECTIVETo identify the frequency that sperm banking was used by men being treated for testicular cancer at our institution, and to characterize the differences between men choosing to bank sperm or not, and outcomes in terms of after-treatment pregnancies.
PATIENTS AND METHODSA questionnaire addressing sperm banking and fertility was administered to men treated for testicular cancer at our institution between 1994 and 2004; the results were evaluated statistically.
RESULTSOverall, 31 of 129 (24%) respondents had banked sperm. Of these, two had used their banked sperm to father a child, and 12 had had children naturally. Men who banked sperm were a mean of 10.3 years younger ( P < 0.001) and less likely to have children at the time of diagnosis ( P < 0.025) than men choosing not to bank sperm. The cost of banking sperm was reported to include a mean fee of US $358 (median 300, range 0-1000), and a mean annual maintenance fee of $243.86 (median 300, range 0-1200).
CONCLUSIONSOnly a minority of men in this study chose to bank sperm (24%). Among those who did, the use of banked sperm was low ( < 10%), and many men could have children without using banked sperm. Given the relatively high costs of sperm banking and the low rate of sample use, patients should be counselled on the costs and benefits of sperm banking before treatment for testicular cancer.
Rate of conversion to an open procedure is significantly impacted by surgical indication, specimen size, and surgical technique. Any conversion is associated with an increased perioperative morbidity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.